Prima BioMed Ltd (PBMD) Gains as Analyst Sees Over 400% Upside
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- S&P 500 edges down with Iran and earnings season in focus
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- S&P 500 edges down with Iran and earnings season in focus
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
After-Hours Stock Movers 12/30: (PBMD) (CMRX) Higher; (AEZS) Lower (more...)
December 30, 2015 5:56 PM ESTPrima Biomed (NASDAQ: PBMD) 6.3% HIGHER; Roth Capital initiates coverage with a Buy rating and a price target of $6.00.
Chimerix (NASDAQ: CMRX) 4.4% HIGHER; In a 13G filing Steven... More
Roth Capital Starts Prima Biomed (PBMD) at Buy; $6 PT
December 30, 2015 4:37 PM ESTRoth Capital initiates coverage on Prima Biomed (NASDAQ: PBMD) with a Buy rating and a price target of $6.00.
Analyst Joseph Pantginis commented, "We are initiating coverage of Prima with a Buy rating and $6 price target. We believe Prima is in a leading position... More
